Taysha Gene Therapies, Inc. (TSHA) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $96.38M | +8.5% |
| 2024 | $88.84M | -9.2% |
| 2023 | $97.79M | -22.0% |
| 2022 | $125.33M | +5.7% |
| 2021 | $118.57M | +1464.5% |
| 2020 | $7.58M | +4952.7% |
| 2019 | $150.0K | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $96.38M | +8.5% |
| 2024 | $88.84M | -9.2% |
| 2023 | $97.79M | -22.0% |
| 2022 | $125.33M | +5.7% |
| 2021 | $118.57M | +1464.5% |
| 2020 | $7.58M | +4952.7% |
| 2019 | $150.0K | — |